Leen Limbourg brings over 15 years of experience in the biopharmaceutical industry in international medico-marketing functions, development and strategic planning. Prior to becoming a founding partner of atoms & art, Leen was director medical & scientific affairs at TiGenix NV where she was the medical lead for the first authorized advanced therapy medicinal product and the strategic development of the stem cell platform. Between 2005 and 2009 she was member of the global launch team for the immunology franchise at UCB.
Leen started her career in the life science industry in 2000 at Organon, where she held various positions with increasing responsibilities in the medical and health economics department.
She holds a Medical Degree from the University of Leuven, studied strategic health economics at Stockholm School of Economics and received her MBA from Vlerick Leuven Ghent Management School.